Passage BIO, Inc. Files 8-K with Corporate Updates
Ticker: PASG · Form: 8-K · Filed: Jul 14, 2025 · CIK: 1787297
Sentiment: neutral
Topics: corporate-governance, filing-update
Related Tickers: BIO
TL;DR
Passage BIO filed an 8-K detailing corporate changes and financial updates.
AI Summary
Passage BIO, Inc. filed an 8-K on July 14, 2025, reporting events as of July 10, 2025. The filing indicates material modifications to security holder rights, amendments to its articles of incorporation or bylaws, and other events. It also includes financial statements and exhibits.
Why It Matters
This 8-K filing signals significant corporate actions by Passage BIO, Inc., which could impact its structure, governance, or financial reporting, requiring investor attention.
Risk Assessment
Risk Level: medium — Material modifications to rights of security holders and amendments to governing documents can introduce new risks or alter existing ones for investors.
Key Players & Entities
- Passage BIO, Inc. (company) — Registrant
- July 10, 2025 (date) — Earliest event reported
- July 14, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Philadelphia, PA (location) — Principal executive office location
FAQ
What specific material modifications were made to the rights of Passage BIO, Inc. security holders?
The filing indicates material modifications to the rights of security holders, but the specific details of these modifications are not provided in the provided text excerpt.
What amendments were made to Passage BIO, Inc.'s articles of incorporation or bylaws?
The filing states that there were amendments to the articles of incorporation or bylaws, but the specific nature of these amendments is not detailed in the excerpt.
What are the 'other events' reported by Passage BIO, Inc. in this 8-K filing?
The filing lists 'Other Events' as an item, but the specific events are not described in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on July 10, 2025.
Where are Passage BIO, Inc.'s principal executive offices located?
Passage BIO, Inc.'s principal executive offices are located at One Commerce Square, 2005 Market Street, 39th Floor, Philadelphia, PA 19103.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 14, 2025 regarding Passage BIO, Inc. (PASG).